Daily Clinical Briefing · Educational reading for healthcare professionals
Early Lyme tests may be negative, while antibodies can remain positive long after successful treatment.
In suspected neuroborreliosis, collect same-day serum and cerebrospinal fluid samples; a raised cerebrospinal fluid white cell count provides stronger evidence of active inflammation than persistent antibodies alone.
A patient presents with a characteristic expanding rash suggesting erythema migrans. Their Lyme serology is negative. Does that make Lyme disease unlikely?
Not necessarily. Around half of patients with early erythema migrans have negative serology because antibodies have not yet developed. In this setting, the rash is a clinical diagnosis, and treatment should not wait for a positive blood test.
The difficulty is that Lyme serology can be misleading at both ends of the illness. Early infection may produce negative results, while antibodies can remain detectable for years after treatment.
Two-tier testing uses an initial IgG/IgM screening assay, followed by an immunoblot when the screening result is positive or equivocal. The results need interpretation alongside the patient's symptoms and the timing of their illness. Persistent IgM or IgG positivity alone cannot establish active infection, and repeating serology is not a useful way to demonstrate cure.
Investigating neuroborreliosis
Neurological Lyme disease creates another diagnostic challenge. Intrathecal antibody production can support the diagnosis of neuroborreliosis, but cerebrospinal fluid antibodies may also remain detectable for years.
The more useful evidence of active inflammation is cerebrospinal fluid pleocytosis. In suspected neuroborreliosis, serum and cerebrospinal fluid should be collected on the same day so that a reference laboratory can calculate the antibody index. The cerebrospinal fluid white cell count helps establish whether inflammation is active. PCR has poor sensitivity and usually adds little.
Treatment also depends on the clinical syndrome. Oral doxycycline is appropriate for most early neuroborreliosis, including cranial nerve palsies. Intravenous ceftriaxone has a role in late disease involving brain or spinal cord parenchyma and severe Lyme carditis. Neurological involvement alone does not automatically require intravenous antibiotics.
There is also uncertainty around treatment duration. The discussion contrasts a 21-day UK course for erythema migrans with evidence that seven days of doxycycline was non-inferior to 14 days. That finding raises questions about the shortest effective treatment, although it does not settle them.
When symptoms persist after treatment
Some patients experience substantial fatigue, cognitive difficulties and musculoskeletal pain after appropriate Lyme treatment. These symptoms are genuine and may be disabling.
Post-treatment Lyme disease syndrome remains incompletely understood, but persistent symptoms do not necessarily indicate ongoing live infection. Prolonged antibiotic courses have not demonstrated benefit for this syndrome.
Patients may understandably pursue further testing, including through private providers. The relevant distinction is whether the laboratory uses validated methods. Some private practitioners use established reference laboratories, while unvalidated cellular tests and CD57 assays cannot reliably establish Lyme disease.
The practical challenge is to make the diagnosis at the right time, use appropriate investigations for the suspected syndrome and recognise when additional treatment may cause more harm than benefit. For patients with continuing symptoms, revisit the original diagnostic evidence, assess alternative causes and avoid treating persistent antibodies as proof of active infection.
Lyme serology can be negative in early erythema migrans and remain positive long after infection. The discussion covers two-tier testing, cerebrospinal fluid investigations for neuroborreliosis, antibiotic selection and the assessment of persistent symptoms without unnecessary retreatment.
Doctors outside formal internal medicine training can demonstrate equivalent competence through an alternative certificate. Requirements include relevant post-foundation experience, an eligible certifying consultant, structured workplace assessments and organised portfolio evidence, including patient logs and completed audit cycles.
Treat characteristic erythema migrans on clinical grounds without waiting for serology. For suspected neuroborreliosis, arrange appropriate paired serum and cerebrospinal fluid investigations, including the cerebrospinal fluid white cell count.
When patients report persistent symptoms after Lyme treatment, review their original diagnosis and investigate alternative explanations. Check the validity of any additional tests rather than using persistent antibody positivity to justify prolonged antibiotics.
An adult presents with a characteristic expanding erythema migrans rash, but an early Lyme antibody test is negative. What is the most appropriate next management step?
Begin appropriate antibiotic treatment based on the clinical diagnosis. Around half of patients with early erythema migrans have negative serology because detectable antibodies have not yet developed.
An adult with early Lyme neuroborreliosis has a cranial nerve palsy but no evidence of brain or spinal cord parenchymal involvement. The patient can take oral medication. Which antibiotic is appropriate?
Oral doxycycline is appropriate for most early neuroborreliosis, including presentations with cranial nerve palsy. Intravenous ceftriaxone is generally reserved for situations such as late parenchymal neuroborreliosis or severe Lyme carditis.
A patient experiences persistent fatigue, difficulty concentrating and muscle aches after completing appropriate treatment for confirmed Lyme disease. Repeat serology remains positive. How should this result influence further management?
Persistent antibodies do not establish ongoing infection and may remain detectable for years. Acknowledge the symptoms, reassess the original diagnostic evidence and investigate alternative causes rather than prescribing prolonged antibiotics for post-treatment Lyme disease syndrome.
Daily Clinical Briefings are prepared using ChatGPT Pro from the show notes and educational output for that day’s episodes. Iain Beardsell then checks the briefing for accuracy.
This describes the current briefing process. Item-specific review dates are shown only where documented. The original podcasts remain the sources; MedPod’s briefing is additional educational material.
Read about MedPod’s editorial approach
Report an error or source concern — please include the article title and link, without patient-identifying information.
.svg)